HHV-6 Immunohistochemistry (IHC)


   Infertility

Pregnant woman
IHC - HHV-6 in Endometrium
Toddler and smiling mother

A 2016 study by Marci et al., showed that 43% of infertile women tested positive for HHV-6 with 0% of the fertile women testing positive for the virus. The authors of this PLOS study concluded that HHV-6 may reactivate due to hormonal changes which could make the uterine environment inhospitable for implantation and fetal development. Further clinical studies are needed to determine the role that HHV-6 plays in fertility.

Coppe Laboratories’ HHV-6 IHC testing has proven to be a highly sensitive and specific method for determining active HHV-6 in tissue biopsy samples.

Related Reading

Presence of HHV-6A in Endometrial Epithelial Cells from Women with Primary Unexplained Infertility
Marci et al
Study reporting 43% positivity for HHV-6A DNA in women with unexplained infertility
2016, PLoS ONE

Human Herpesviruses 6A and 6B in Reproductive Diseases
Komaroff A, Rizzo R, Ecker J
HHV-6A infection may be trigger of primary unexplained infertility; Further research required
2021, Front. Immunol.

New York Physicians: No approved waiver necessary. Coppe Laboratories holds a license with the NYSDOH (#PFI 9230) and is permitted to accept orders for the following tests: #3008 Powassan IgG/IgM; #5000 West Nile Virus IgM; #2001 HHV 6 IHC; #20011 HHV 6 IHC (Endometrial)

Test Menu